Name
Intellia Therapeutics
Company Description
Intellia Therapeutics, Inc. is a clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. Leveraging gene editing technology, Intellia is developing novel, first-in-class medicines to meet important unmet needs and advance treatments for patients.
Featured Exhibitor
Yes
Address
40 Erie Street, Suite 130
Cambridge, MA 02139
United States

Badges

Featured Exhibitor

Share: